Researchers from McMaster University and the Firestone Institute for Respiratory Health at St. Joseph's Healthcare Hamilton, together with colleagues at other partnering institutions, have developed a new method to treat ...
May 22, 2018
0
29
Two new studies of patients with difficult-to-control asthma show that the eczema drug dupilumab alleviates asthma symptoms and improves patients' ability to breathe better than standard therapies. Dupilumab, an injectable ...
May 21, 2018
0
165
Asthma outcomes still vary widely across England and appear to be influenced by region and affluence despite falling rates of asthma deaths, emergency hospital admissions and prevalence, suggests a study published in the ...
May 14, 2018
0
2
Researchers at Western University and McMaster University are developing an innovative lung imaging method that provides a unique window on asthma that is aimed at guiding and personalizing treatment for Canadians with severe, ...
Apr 4, 2018
0
2
A team of researchers from the NIHR Leicester Biomedical Research Centre - a partnership between Leicester's Hospitals, the University of Leicester and Loughborough University - has identified biological variations in lung ...
Mar 14, 2018
0
219
Serious asthma attacks in adults can be reduced by a temporary but significant increase in the dose of inhaled steroids during severe episodes of asthma, according to a new UK-wide study led by experts at the University of ...
Mar 8, 2018
0
6
A team at The University of Manchester have found that in a minority of patients they studied, a standard treatment for asthma—oral steroids—was associated with increased levels of the treatable mould Aspergillus in the ...
Jan 15, 2018
0
36
(HealthDay)—Nucala (mepolizumab) has been approved by the U.S. Food and Drug Administration as the first remedy to treat adults with eosinophilic granulomatosis with polyangiitis, a rare autoimmune disease that leads to ...
Dec 12, 2017
0
14
While the microbiome has gained significant attention for its impact on digestive health in recent years, its effect on lung disease has largely remained unstudied.
Oct 24, 2017
0
1
(HealthDay)—A "biologic" drug in development to treat severe asthma reduces the rate of serious attacks by about two-thirds compared to a placebo drug, according to preliminary research findings.
Sep 7, 2017
0
73
